Management of pain and spinal cord compression in patients with advanced cancer

Annals of Internal Medicine

Volumn 131, Issue 1, 1999, Pages 37-46

  Abrahm, Janet L ^a   Lob, Bernard ^a,b   Abrahm, Janet ^a   Block, Susan ^b   Breitbart, William ^a,b   Byock, Ira R ^a,b   Faber Langendoen, Kathy ^a   Kitchens Jr , Lloyd W ^a   Lanken, Paul ^a   Lynn, Joanne ^b   Meier, Diane ^a   Quill, Timothy E ^b   Thibault, George ^a   Tulsky, James ^a   Snyder, Lois ^a  

^a AMERICAN COLLEGE OF PHYSICIANS   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUTAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE;

ADVANCED CANCER; AGED; ANALGESIA; CANCER RADIOTHERAPY; CASE REPORT; HUMAN; MALE; MORBIDITY; PAIN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; REVIEW; SPINAL CORD COMPRESSION;

EID: 0033529395     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-131-1-199907060-00009     Document Type: Review

References (115)

1. Zech DF, Grond S, Lynch J, Hertel D, Lehmann KA. Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study. Pain. 1995;63:65-76.
2. Cancer Pain Relief: With a Guide to Opioid Availability. 2d ed. Geneva: World Health Organization; 1996.
3. Jacox A. Carr DB. Payne R, Berde CB, Breitbart W, Cain JM, et al. Management of Cancer Pain. Clinical practice guideline no. 9. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research; 1994. ACHPR publication no. 94-0592.
4. Cancer Pain Assessment and Treatment Curriculum Guidelines. The Ad Hoc Committee on Cancer Pain of the American Society of Clinical Oncology. J Clin Oncol. 1992;10:1976-82.
5. Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain. Skokie, IL: American Pain Soc; 1992.
6. Practice guidelines for cancer pain management. A report by the American Society of Anesthesiologists Task Force on Pain Management, Cancer Pain Section. Anesthesiology. 1996;84:1243-57.
7. The management of chronic pain in older persons: AGS Panel on Chronic Pain in Older Persons. American Geriatrics Society. J Am Geriatr Soc. 1998;46:635-51.
8. Foley KM. Management of cancer pain. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 5th ed. Philadelphia: Lippincott-Raven; 1997:2807-41.
9. Ingham J, Portenoy RK. The measurement of pain and other symptoms. In: Doyle D, Hanks GW, MacDonald N, eds. Oxford Textbook of Palliative Medicine. 2d ed. Oxford: Oxford Univ Pr; 1997:203-19.
10. McGuire DB. The multiple dimensions of cancer pain: a framework for assessment and management. In: McGuire DB, Yarbro CH, Ferrell BR, eds. Cancer Pain Management. 2d ed. Boston: Jones and Bartlett; 1995:1-17.
11. Levy MH. Pharmacologic treatment of cancer pain. N Engl J Med. 1996;335:1124-32.
12. Cherny NI, Foley KM. Pain and Palliative Care. Hematology/Oncology Clinics of North America, v 10. Philadelphia: WB Saunders; 1996.
13. Cherny NI, Portenoy RK. Cancer pain management. Current strategy. Cancer. 1993;72(11 Suppl):3393-415.
14. Foley KM. Pain assessment and cancer pain syndromes. In: Doyle D, Hanks GW, MacDonald N, eds. Oxford Textbook of Palliative Medicine. 2d ed. Oxford: Oxford Univ Pr; 1997:310-31.
15. Loblaw DA, Laperierre NJ. Emergency treatment of malignant extradural spinal cord compression: an evidence-based guideline. J Clin Oncol. 1998;16:1613-24.
16. Cleeland CS, Gonin R. Hatfield AK, Edmonson JH, Blum RH. Stewart JA, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med. 1994;330:592-6.
17. Grossman SA, Sheidler VR, Swedeen K, Mucenski J. Piantadosi S. Correlation of patient and caregiver ratings of cancer pain. J Pain Symptom Manage. 1991;6:53-7.
18. Cleeland CS, Gonin R, Baez L, Loehrer P, Pandya KJ. Pain and treatment of pain in minority patients with cancer. The Eastern Cooperative Oncology Group Minority Outpatient Pain Study. Ann Intern Med. 1997;127:813-6.
19. Breitbart W, Rosenfeld BD. Passik SD, McDonald MV, Thaler H, Portenoy RK. The undertreatment of pain in ambulatory AIDS patients. Pain. 1996:65:243-9.
20. Breitbart W, Rosenfeld B, Passik S, Kaim M. Funesti-Esch J, Stein K. A comparison of pain report and adequacy of analgesic therapy in ambulatory AIDS patients with and without a history of substance abuse. Pain. 1997;72:235-43.
21. Ferrell BA, Ferrell BR, Rivera L. Pain in cognitively impaired nursing home patients. J Pain Symptom Manage. 1995;10:591-8.
22. Eisenberg E, Berkey CS, Carr DB, Mosteller F, Chalmers TC. Efficacy and safety of non-steroidal antiinflammatory drugs for cancer pain: a metaanalysis. J Clin Oncol. 1994;12:2756-65.
23. Gloth FM 3d. Concerns with chronic analgesic therapy in elderly patients. Am J Med. 1996:101 (Suppl 1):19S-24S.
24. Ferrell BA. Pain evaluation and management in the nursing home. Ann Intern Med. 1995;123:681-7.
25. Roth SH. Merits and liabilities of NSAID therapy. Rheum Dis Clin North Am. 1989;15:479-98.
26. Hawkey CJ, Karrasch KA, Szczepanski L, Walker DG, Barkun A, Swannell AJ, et al. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group. N Engl J Med. 1998;338:727-34.
27. Yeomans ND, Tulassay Z, Juhasz L, Racz I, Howard JM, van Rensburg CJ, et al. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group. N Engl J Med. 1998;338:719-26.
28. Westerling D, Lindahl S, Andersson KE, Andersson A. Absorption and bioavailability of rectally administered morphine in women. Eur J Clin Pharmacol. 1982;23:59-64.
29. De Conno F, Ripamonti C, Saiti L, MacEachern T, Hanson J, Bruera E. Role of rectal route in treating cancer pain: a randomized crossover clinical trial of oral versus rectal morphine administration in opioid-naive cancer patients with pain. J Clin Oncol. 1995;13:1004-8.
30. Kaiko R, Lacouture P, Hopf K, Brown J, Goldenheim P. Analgesic onset and potency of oral controlled-release (CR) oxycodone and CR morphine [Abstract]. Clin Pharmacol Ther. 1996;59:130.
31. Bruera ED, Chadwick S, Bacovsky R, MacDonald N. Continuous subcutaneous infusion of narcotics using a portable disposable pump. J Palliat Care. 1985;1:46-7.
32. Broomhead A, West R, Knox K, Kadirgamanathan G, Krueger D, Malick JB. Morphine bioavailability and pharmacokinetic comparison of Kadian (sustained release morphine sulfate) capsules and pellets ("Sprinkling") in human volunteers under fasted or fed conditions [Abstract]. Proceedings of the American Society of Clinical Oncology. 1997;16:61a.
33. Varvel JR, Shafer SL, Hwang SS, Coen PA, Stanski DR. Absorption characteristics of transdermally administered fentanyl. Anesthesiology. 1989;70:928-34.
34. Portenoy RK, Southam MA, Gupta SK, Lapin J, Layman M, Inturrisi CE, et al. Transdermal fentanyl for cancer pain. Repeated dose pharmacokinetics. Anesthesiology. 1993;78:36-43.
35. Donner B, Zenz M, Tryba M, Strumpf M. Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain. Pain. 1996;64:527-34.
36. Hanks GW, Cherny N. Opioid analgesic therapy. In: Doyle D, Hanks GW, MacDonald N, eds. Oxford Textbook of Palliative Medicine. 2d ed. Oxford: Oxford Univ Pr; 1997:351-5.
37. Kaplan R. Parris WC Citron ML, Zhukovsky D, Reder RF, Buckley BJ, et al. Comparison of controlled-release and immediate-release oxycodone tablets in patients with cancer pain. J Clin Oncol. 1998;16:3230-7.
38. Fine PG, Marcus M, De Boer AJ, Van der Oord B. An open label study of oral transmucosal fentanyl citrate (OTFC) for the treatment of break-through cancer pain. Pain. 1991;45:149-53.
39. Streisand JB, Varvel JR, Stanski DR, Le Maire L, Ashburn MA, Hague Bl, et al. Absorption and bioavailability of oral transmucosal fentanyl citrate. Anesthesiology. 1991;75:223-9.
40. Christie JM, Simmonds MA, Patt R, Coluzzi P, Busch MA, Nordbrock E, et al. Dose-titration, multicenter study of oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients using transdermal fentanyl for persistent pain. J Clin Oncol. 1998;16:3238-45.
41. Lyss AP. Long-term use of oral transmucosal fentanyl citrate (OTFC) for breakthrough pain in cancer patients [Abstract]. Proc ASCO. 1997;16:41a.
42. Farrar JT, Cleary J, Rauck R, Busch M, Nordbrock E. Oral transmucosal fentanyl citrate: randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer patients. J Natl Cancer Inst. 1998;90:611-6.
43. Bruera E, Suarez-Almazor M, Velasco A, Bertolino M, MacDonald SM, Hanson J. The assessment of constipation in terminal cancer patients admitted to a palliative care unit: a retrospective review. J Pain Symptom Manage. 1994;9:515-9.
44. Glare P, Lickiss JN. Unrecognized constipation in patients with advanced cancer: a recipe for disaster. J Pain Symptom Manage. 1992;7:369-71.
45. Constipation, diarrhea, and other Gl problems. In: Billings JA. Outpatient Management of Advanced Cancer: Symptom Control, Support, and Hospicein-the-Home. Philadelphia: Lippincott: 1985:69-76.
46. Patt RB, Ellison NM. Breakthrough pain in cancer patients: characteristics, prevalence, and treatment. Oncology (Huntingt). 1998;12:1035-46.
47. Ahmedzai S, Brooks D. Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group. J Pain Symptom Manage. 1997;13:254-61.
48. Payne R, Mathias SD. Pasta DJ, Wanke LA, Williams R, Mahmoud R. Quality of life and cancer pain: satisfaction and side effects with transdermal fentanyl versus oral morphine. J Clin Oncol. 1998;16:1583-93.
49. Coyle N, Cherny N. Portenoy RK. Pharmacologic management of cancer pain. In: McGuire DB, Yarbro CH, Ferrell BR, eds. Cancer Pain Management. 2d ed. Boston: Jones and Bartlett; 1995:89-130.
50. Kaiko RF, Foley KM, Grabinski PY, Heidrich G, Rogers AG, Inturrisi CE, et al. Central nervous system excitatory effects of meperidine in cancer patients. Ann Neurol. 1983;13:180-5.
51. Spross JA, Wolff Burke M. Nonpharmacologic management of cancer pain. In: McGuire DB, Yarbro CH, Ferrell BR, eds. Cancer Pain Management. 2d ed. Boston: Jones and Bartlett; 1995:159-205.
52. Rhiner M, Ferrell BR, Ferrell BA, Grant MM. A structured nondrug intervention program for cancer pain. Cancer Pract. 1993;1:137-43.
53. McCaffery M. Wolff M. Pain relief using cutaneous modalities, positioning, and movement. Hosp J. 1992;8:121-54.
54. Ferrell-Torry A, Glick O. The use of therapeutic massage as a nursing intervention to modify anxiety and the perception of cancer pain. Cancer Nurs. 1993;16:93-101.
55. Syrjala KL, Donaldson GW, Davis MW, Kippes ME, Carr JE. Relaxation and imagery and cognitive-behavioral training reduce pain during cancer treatment: a controlled clinical trial. Pain. 1995;63:189-98.
56. Benson H, Beary JF, Carol MP. The relaxation response. Psychiatry. 1974;37:37-46.
57. Syrjala KL, Roth-Roemer SL. Hypnosis and suggestion for managing cancer pain. In: Barber J, ed. Hypnosis and Suggestion in the Treatment of Pain. New York: WW Norton; 1996:121-57.
58. Loscalzo M. Psychological approaches to the management of pain in patients with advanced cancer. Hematol Oncol Clin North Am. 1996;10:139-55.
59. Breitbart W, Passik SD, Rosenfeld BD. Psychiatric and psychological aspects of cancer pain. In: Wall PD, Melzack R, eds. Textbook of Pain. 3d ed. New York: Churchill Livingstone; 1994:825-59.
60. Hortobagyi GN, Theriault RL, Porter L, Blayney D, Lipton A, Sinoff C, et al. Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group. N Engl J Med. 1996;335:1785-91.
61. Hortobagyi GN, Theriault RL, Lipton A, Porter L, Blayney D, Sinoff C et al. Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group. J Clin Oncol. 1998;16:2038-44.
62. Lipton A. Bisphosphonates treatment of lytic bone metastases. ASCO Education Book, Spring 1998. Philadelphia: WB Saunders; 1998:94-9.
63. Coleman RE. Purohilt OP. Vinholes JJ, Zekri J. High dose pamidronate: clinical and biochemical effects in metastatic bone disease. Cancer. 1997;80:1686-90.
64. Berenson JR, Lichtenstein A, Porter L, Dimopoulos MA. Bordoni R, George S, et al. Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. J Clin Oncol. 1998;16:593-602.
65. Adami S. Bisphosphonates in prostate carcinoma. Cancer. 1997;80(8 Suppl):1674-9.
66. Robinson RG, Preston DF, Baxter KG, Dusing RW, Spicer JA. Clinical experience with strontium-89 in prostatic and breast cancer patients. Semin Oncol. 1993;20(3 Suppl 2):44-8.
67. Janjan NA. Radiation for bone metastases: conventional techniques and the role of systemic radiopharmaceuticals. Cancer. 1997;80(8 Suppl):1628-45.
68. McEwan AJ. Unsealed source therapy of painful bone metastases: an update. Semin Nucl Med. 1997;27:165-82.
69. Coleman RE. Management of bone metastases. ASCO Education Book, Spring 1998. Philadelphia: WB Saunders; 1998:100-8.
70. Lewington VJ, McEwan AJ, Ackery DM, Bayly RJ, Keeling DH, Macleod PM, et al. A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone. Eur J Cancer. 1991;27:954-8.
71. Serafini AN, Houston SJ, Resche I, Quick DP, Grund FM, Ell PJ, et al. Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled trial. J Clin Oncol. 1998;16:1574-81.
72. Wycross RG. Clinical experience with diamorphine in advanced malignant disease. Int J Clin Pharmacol. 1974;7:184-98.
73. Kanner RM, Foley KM. Patterns of narcotic drug use in a cancer pain clinic. Ann N Y Acad Sci. 1981;362:161-72.
74. Porter J, Jick H. Addiction rare in patients treated with narcotics [Letter]. N Engl J Med. 1980;302:123.
75. Mercadante S. Diarrhea, malabsorption, and constipation. In: Berger AM, Portenoy RK, Weissman DE, eds. Principles and Practice of Supportive Oncology. Philadelphia: Lippincott-Raven; 1998:191-205.
76. Red Book. Montvale, NJ: Medical Economics; 1998.
77. Vainio A, Ollila J, Matikainen E, Rosenberg P, Kalso E. Driving ability in cancer patients receiving long-term morphine analgesia. Lancet. 1995;346:667-70.
78. Bruera E, Belzile M, Pituskin E, Fainsinger R, Darke A, Harsanyi Z, et al. Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain. J Clin Oncol. 1998;16:3222-9.
79. Baines M. Nausea and vomiting in the patient with advanced cancer. J Pain Symptom Manage. 1988;3:815.
80. Currow DC, Coughlan M, Fardell B, Cooney NJ. Use of ondansetron in palliative medicine. J Pain Symptom Manage. 1997;13:302-7.
81. Ripamonti C. Bowel obstruction. In: Berger AM, Portenoy RK, Weissman DE, eds. Principles and Practice of Supportive Oncology. Philadelphia: Lippincott-Raven; 1998:207-16.
82. Bruera E, Lawlor P, Watanabe S, Turner K. Hanson J. The effects of opioid rotation (OR), dose ratio (DR) on pain control and cognition in patients (P) with cancer pain [Abstract]. Proceedings of the American Society of Clinical Oncology. 1997;16:62a.
83. Lichter I. Nausea and vomiting in patients with cancer. Hematol Oncol Clin North Am. 1996;10:207-20.
84. Ripamonti C, Groff L, Brunelli C, Polastri D, Stavrakis A, De Conno F. Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio? J Clin Oncol. 1998;- 16:3216-21.
85. Mercadante S, Casuccio A, Agnello A, Serretta R, Calderone L, Barresi L Morphine versus methadone in the pain treatment of advanced-cancer patients followed up at home. J Clin Oncol. 1998;16:3655-61.
86. Foley KM, Houde RW. Methadone in cancer pain management: individualize dose and titrate to effect [Editorial]. J Clin Oncol. 1998;16:3213-5.
87. Manfredi PL, Ribeiro S, Chandler SW, Payne R. Inappropriate use of naloxone in cancer patients with pain. J Pain Symptom Manage. 1996;11:131-4.
88. Payne R. Pharmacologic management of pain. In: Berger AM, Portenoy RK, Weissman DE, eds. Principles and Practice of Supportive Oncology. Philadelphia: Lippincott-Raven; 1998:61-75.
89. Caracini A, Martini C. Neurological problems. In: Doyle D, Hanks GW, MacDonald N, eds. Oxford Textbook of Palliative Medicine. 2d ed. Oxford: Oxford Univ Pr; 1997:727-49.
90. Rodichok LD, Harper GR, Ruckdeschel JC, Price A, Roberson G, Barron KD, et al. Early diagnosis of spinal epidural metastases. Am J Med. 1981;70:1181-8.
91. Rodichok LD, Ruckdeschel JD, Harper GR. Cooper G, Prevosti L, Fernando L, et al. Early detection and treatment of spinal epidural metastases: the role of myelography. Ann Neurol. 1986;20:696-702.
92. Portenoy RK, Galer BS, Salamon O. Freilich M, Finkel JE, Milstein D, et al. Identification of epidural neoplasm. Radiography and bone scintigraphy in the symptomatic and asymptomatic spine. Cancer. 1989;64:2207-13.
93. Portenoy RK, Lipton RB, Foley KM. Back pain in the cancer patient: an algorithm for evaluation and management. Neurology. 1987;37:134-8.
94. Hoskin PJ. Radiotherapy in symptom management. In: Doyle D, Hanks GW, MacDonald N, eds. Oxford Textbook of Palliative Medicine. 2d ed. Oxford: Oxford Univ Pr; 1997:267-82.
95. Pinover WH. Coia LR. Palliative radiation therapy. In: Berger AM, Portenoy RK, Weissman DE, eds. Principles and Practice of Supportive Oncology. Philadelphia: Lippincott-Raven; 1998:603-26.
96. Maranzano E, Latini P. Effectiveness of radiation therapy without surgery in metastatic spinal cord compression: final results from a prospective trial. Int J Radial Oncol Biol Phys. 1995;32:959-67.
97. Siegal T, Siegal T. Current considerations in the management of neoplastic spinal cord compression. Spine. 1989;14:223-8.
98. Sorensen S, Helweg-Larsen S, Mouridsen H, Hansen HH. Effect of high-dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomised trial. Eur J Cancer. 1994;30A:-22-7.
99. Heimdal K, Hirschberg H, Slettebo H. Watne K, Nome O. High incidence of serious side effects of high-dose dexamethasone treatment in patients with epidural spinal cord compression. J Neurooncol. 1992;12:141-4.
100. Cobb CA 3d, Leavens ME, Eckles N. Indications for nonoperative treatment of spinal cord compression due to breast cancer. J Neurosurg. 1977;47:653-8.
101. Posner JB. Neurological Complications of Cancer. Contemporary Neurology Series v 45. Philadelphia: FA Davis; 1995.
102. Young RF, Post EM, King GA. Treatment of spinal epidural metastases. Randomized prospective comparison of laminectomy and radiotherapy. J Neurosurg. 1980;53:741-8.
103. Findlay GF. Adverse effects of the management of malignant spinal cord compression. J Neurol Neurosurg Psychiatry. 1984;47:761-8.
104. Breitbart W, Chochinov HM, Passick S. Psychiatric aspects of palliative care. In: Doyle D. Hanks GW, MacDonald N, eds. Oxford Textbook of Palliative Medicine. 2d ed. Oxford: Oxford Univ Pr; 1997:933-54.
105. Wilwerding MB, Loprinzi CL, Maillaird JA, O'Fallon JR. Miser AW, van Haelst C, et al. A randomized, crossover evaluation of methylphenidate in cancer patients receiving strong narcotics. Support Care Cancer. 1995;3:135-8.
106. Kreeger L, Duncan A, Cowap J. Psychostimulants used for opioid-induced drowsiness (Letter]. J Pain Symptom Manage. 1996;11:1-2.
107. Dalal S, Melzack R. Potentiation of opioid analgesia by psychostimulant drugs: a review. J Pain Symptom Manage. 1998;16:245-53.
108. Holland JC, ed. Psycho-Oncology. New York: Oxford Univ Pr; 1998.
109. Saunders CM, Baines M. Living with Dying: The Management of Terminal Disease. Oxford: Oxford Univ Pr; 1989.
110. Doyle D, Hanks GW, MacDonald N, eds. Oxford Textbook of Palliative Medicine. 2d ed. Oxford: Oxford Univ Pr; 1997.
111. Berger AM, Portenoy RK, Weissman DE, eds. Principles and Practice of Supportive Oncology. Philadelphia: Lippincott-Raven; 1998:191-205.
112. Waller A, Caroline NL. Handbook of Palliative Care in Cancer. Boston: Butterworth-Heinemann; 1996.
113. Storey P, Knight CF, eds. Hospice/Palliative Care Training for Physicians: A Self Study Program. 2d ed. Reston, VA: American Academy of Hospice and Palliative Medicine; 1997.
114. MacDonald N, ed. Palliative Medicine: A Case-Based Manual. Oxford: Oxford Univ Pr; 1997.
115. Caring for the Dying: Identification and Promotion of Physician Competency. Philadelphia: American Board of Internal Medicine; 1996.